comparemela.com

Latest Breaking News On - Condensed consolidated profit - Page 1 : comparemela.com

CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

Issuer: CureVac / Key word: Quarter Results CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update 23.05.2024 / 13:00.

United kingdomUnited statesPatrick perezSarah fakihPierre kemulaAlexander zehnderContract manufacturing organizationRna vaccine programCurevac incExchange commissionSupreme courtDrug administrationGerman federal patent court onCurevac corporate services gmbCorporate communicationsCurevac announces financial results

EQS-News: CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update | Company Announcement

Investegate announcements from EQS-News: CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

United kingdomUnited statesSarah fakihAlexander zehnderPierre kemulaPatrick perezExchange commissionContract manufacturing organizationRna vaccine programCurevac incCurevac corporate services gmbSupreme courtCorporate communicationsGerman federal patent court onDrug administrationCurevac announces financial results

CureVac AG: CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

Organizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1) vaccine

United statesUnited kingdomPatrick perezAlexander zehnderSarah fakihPierre kemulaRna vaccine programExchange commissionContract manufacturing organizationCorporate communicationsCurevac incCurevac corporate services gmbSupreme courtDrug administrationGerman federal patent court onAcuitas therapeutics

EQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update | Company Announcement

Investegate announcements from EQS-News: CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

United statesUnited kingdomFederal republic of germanyPatrick perezAlexander zehnderSarah fakihPierre kemulaThaminda ramanayakeRegional courtGerman federal courtRna vaccine programBiomarin pharmaceuticalsExchange commissionGerman federal patent courtCurevac management teamDistrict court

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

Issuer: CureVac / Key word: Annual Results CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update 24.04.2024 / 13:06.

United statesUnited kingdomFederal republic of germanySarah fakihThaminda ramanayakePierre kemulaPatrick perezAlexander zehnderUniversity of rochester simon school businessClinical trial supply agreement centerCurevac incExchange commissionCorporate developmentSeasonal flu programGerman federal patent courtCorporate communications

vimarsana © 2020. All Rights Reserved.